Breaking News Instant updates and real-time market news.

EVH

Evolent Health

$18.95

0.25 (1.34%)

07:42
11/21/16
11/21
07:42
11/21/16
07:42

Leerink continues positive on Evolent Health heading into 2017

Leerink analyst David Larsen continues to be positive on Evolent Health heading into 2017, and says that management has consistently delivered on promises, including five new partner relationships in 2016, steady organic growth in lives-on-platform from existing customers, a high degree of recurring revenue and steady improvement in EBITDA. The analyst reiterated an Outperform rating on the stock but lowered his price target on the shares to $24 from $28.

  • 29

    Nov

EVH Evolent Health
$18.95

0.25 (1.34%)

11/07/16
ADAM
11/07/16
NO CHANGE
Target $30
ADAM
Buy
Evolent Health weakness a buying opportunity, says Canaccord
Canaccord analyst Richard Close recommends investors buy the recent weakness in Evolent Health as he does not believe the company has suffered the same "weak purchasing environment" that other companies have discussed in their recent earnings calls. Close expects another strong quarterly report for Evolent and believes the company offers a bright spot in healthcare. Close reiterated his Buy rating and $40 price target on Evolent Health shares ahead of the company's Q3 earnings report, which is scheduled for November 9.
11/10/16
COWN
11/10/16
NO CHANGE
Target $35
COWN
Outperform
Evolent Health price target raised to $35 from $30 at Cowen
Cowen analyst Charles Ryhee raised his price target on Evolent Health to $35 from $30 following strong Q3 results and revised its guidance to include Valance and Aldera. The analyst believes with the changes to the ACA as a result of the election, providers will look to companies like Evolent to help drive outcomes to improve reimbursement. Ryhee reiterated his Outperform rating on Evolent Health shares.
11/15/16
COWN
11/15/16
NO CHANGE
Target $35
COWN
Outperform
Evolent Health weakness offers attractive entry point, says Cowen
Cowen analyst Charles Rhyee believes the 10% pullback in Evolent Health shares since the election reflects concerns that repealing and replacing the ACA could mean there will be no more Medicaid expansion. However, he thinks the provision eliminating Medicaid expansion and the associated Federal Medical Assistance Percentages increase may not be included in the Republican ACA-repeal provisions. Also, Rhyee thinks a transition to value-based care will continue even if the ACA is repealed and replaced. He recommends buying amid the post-election weakness and reiterate his $35 price target and Outperform rating on the shares.
11/16/16
WBLR
11/16/16
NO CHANGE
WBLR
Outperform
William Blair calls Evolent top small-cap alpha generation idea
William Blair analyst Ryan Daniels listed his top 10 reasons for why the recent pullback in shares of Evolent Health creates a good entry point. Much of the post-quarter weakness relates to the recent election results, as investors weigh the uncertainty created by a Republican-controlled White House and Congress along with the party's objective to immediately repeal and replace the Affordable Care Act, Daniels tells investors in a research note. The analyst believes the "movement to value-based care in the United States will continue apace" and has "strong" bipartisan support. He also believes Evolent Health's momentum "is quite strong." It is unlikely that the new administration will disrupt the insurance markets so much that tens of millions of Americans suddenly lose coverage in 2019, Daniels tells investors in a research note. He calls Evolent his top small-cap alpha generation idea over the next 12 months and reiterates an Outperform rating on the name.

TODAY'S FREE FLY STORIES

VFC

VF Corp.

$57.14

1.35 (2.42%)

15:36
12/05/16
12/05
15:36
12/05/16
15:36
Technical Analysis
VF Corp. rises, rounding bottom pattern »

The stock is up over 2.3%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYGN

Myriad Genetics

$16.66

0.02 (0.12%)

15:30
12/05/16
12/05
15:30
12/05/16
15:30
Options
Vote of confidence in Myriad Genetics will result in big open interest increase »

Vote of confidence in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

SMTC

Semtech

$30.30

1.2 (4.12%)

15:25
12/05/16
12/05
15:25
12/05/16
15:25
Conference/Events
Semtech management to meet with B. Riley »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 07

    Dec

MMI

Marcus & Millichap

$27.78

0.49 (1.80%)

15:25
12/05/16
12/05
15:25
12/05/16
15:25
Hot Stocks
Marcus & Millichap's IPA unit closes sale of Isle at Arrowhead Ranch for $42M »

Marcus & Millichap…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

15:25
12/05/16
12/05
15:25
12/05/16
15:25
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

RDI

Reading International

$15.76

-0.17 (-1.07%)

15:24
12/05/16
12/05
15:24
12/05/16
15:24
Conference/Events
Reading International management to meet with B. Riley »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

ON

ON Semiconductor

$11.12

0.15 (1.37%)

15:22
12/05/16
12/05
15:22
12/05/16
15:22
Conference/Events
ON Semiconductor management to meet with B. Riley »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

SUP

Superior Industries

$25.43

0.725 (2.94%)

15:20
12/05/16
12/05
15:20
12/05/16
15:20
Conference/Events
Superior Industries management to meet with B. Riley »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

  • 07

    Dec

  • 10

    Jan

VFC

VF Corp.

$57.11

1.315 (2.36%)

15:20
12/05/16
12/05
15:20
12/05/16
15:20
Options
5X average daily option volume in VFC driven by a three-way spread »

5X average daily option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIQ

Alliance HealthCare

15:16
12/05/16
12/05
15:16
12/05/16
15:16
Hot Stocks
Alliance HealthCare Radiology forms partnership with Sodexo Healthcare »

Alliance HealthCare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

15:16
12/05/16
12/05
15:16
12/05/16
15:16
Technical Analysis
NYSE market internals summary »

Breadth is bullish across…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

15:16
12/05/16
12/05
15:16
12/05/16
15:16
Technical Analysis
NASDAQ market internals summary »

Volume is heavier than…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STO

Statoil

$17.74

0.025 (0.14%)

, BP

BP

$35.59

0.11 (0.31%)

15:15
12/05/16
12/05
15:15
12/05/16
15:15
Periodicals
Statoil, BP, Total group awarded first block in Salina auction, Reuters says »

Mexico has awarded a…

STO

Statoil

$17.74

0.025 (0.14%)

BP

BP

$35.59

0.11 (0.31%)

TOT

Total

$48.33

0.55 (1.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCO

Clear Channel Outdoor

$5.55

-0.1 (-1.77%)

15:10
12/05/16
12/05
15:10
12/05/16
15:10
Hot Stocks
Clear Channel Airports awarded 10-year contract extension by MNAA »

Clear Channel Airports, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$38.78

0.1735 (0.45%)

, INTC

Intel

$34.16

0.4 (1.18%)

15:06
12/05/16
12/05
15:06
12/05/16
15:06
Hot Stocks
AT&T launches first 5G business customer trial with Intel and Ericsson »

AT&T (T) said it has…

T

AT&T

$38.78

0.1735 (0.45%)

INTC

Intel

$34.16

0.4 (1.18%)

ERIC

Ericsson

$5.16

0.04 (0.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 07

    Dec

  • 07

    Dec

  • 14

    Dec

  • 29

    Mar

LLL

L-3 Communications

$157.70

0.47 (0.30%)

15:03
12/05/16
12/05
15:03
12/05/16
15:03
Conference/Events
L-3 Communications to host investor meeting with conference call hookup »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

PARR

Par Pacific

$15.19

0.2 (1.33%)

14:55
12/05/16
12/05
14:55
12/05/16
14:55
Hot Stocks
Whitebox Advisors cuts Par Pacific stake to 16.4% from 18.2% »

Whitebox Advisors, which…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:55
12/05/16
12/05
14:55
12/05/16
14:55
Conference/Events
U.S. Vice President Biden speaks on financial regulation »

Vice President Biden,…

GBT

Global Blood Therapeutics

$19.10

-0.1 (-0.52%)

14:55
12/05/16
12/05
14:55
12/05/16
14:55
Conference/Events
Global Blood Therapeutics to hold a webcast »

Management holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 14

    Dec

  • 15

    Dec

  • 19

    Dec

NEWM

New Media

$15.93

-0.06 (-0.38%)

, DTSI

DTS, Inc.

14:55
12/05/16
12/05
14:55
12/05/16
14:55
Hot Stocks
New Media to replace DTS, Inc. in S&P 600 as of 12/5 close »

S&P SmallCap 600…

NEWM

New Media

$15.93

-0.06 (-0.38%)

DTSI

DTS, Inc.

TSRA

Tessera

$39.30

0.2 (0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBHC

National Bank

$29.99

0.835 (2.86%)

, ININ

Interactive Intelligence

14:55
12/05/16
12/05
14:55
12/05/16
14:55
Hot Stocks
National Bank to replace Interactive Intelligence in S&P 600 as of 12/5 close »

Genesys is acquiring…

NBHC

National Bank

$29.99

0.835 (2.86%)

ININ

Interactive Intelligence

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDC

Belden

$74.55

0.46 (0.62%)

14:50
12/05/16
12/05
14:50
12/05/16
14:50
Hot Stocks
Belden CEO says targets long-term revenue growth 5%-7% »

Speaking during the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

IMGN

ImmunoGen

$1.88

0.11 (6.21%)

14:49
12/05/16
12/05
14:49
12/05/16
14:49
Hot Stocks
Breaking Hot Stocks news story on ImmunoGen »

ImmunoGen to submit IND…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COUP

Coupa Software

$26.29

-1.49 (-5.36%)

14:49
12/05/16
12/05
14:49
12/05/16
14:49
Options
Coupa Software options imply 19.3% move in share price post-earnings, below median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

IMGN

ImmunoGen

$1.88

0.11 (6.21%)

14:47
12/05/16
12/05
14:47
12/05/16
14:47
Hot Stocks
ImmunoGen reports preclinical data on IMGN632 presented at ASH meeting »

ImmunoGen announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.